ArticleBlood advances2024
Need for consensus on primary end points and efficacy definitions in trials for adult acute lymphoblastic leukemia.
Matthew J WieduwiltPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it